dm+d
Unassigned
New Medicines
Complicated urinary tract infection - IV formulation
Information
New molecular entity
Iterum Therapeutics
Iterum Therapeutics
Development and Regulatory status
Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials
Category
Penem antibiotic active against resistant enterobacteriaceae
In England (2018/19), ~190,000 hospital admissions were for complicated urinary tract infections, including pyelonephritis and sepsis due to gram-negative bacteria. [10]
Complicated urinary tract infection - IV formulation
Intravenous